J Martin Carroll is Director of Catalent, Inc.. Currently has a direct ownership of 28,071 shares of CTLT, which is worth approximately $1.64 Million. The most recent transaction as insider was on Oct 27, 2023, when has been sold 6,993 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.1K
0% 3M change
0% 12M change
Total Value Held $1.64 Million

J MARTIN CARROLL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 27 2023
BUY
Grant, award, or other acquisition
-
6,993 Added 19.94%
28,071 Common Stock
Jul 01 2023
BUY
Grant, award, or other acquisition
-
555 Added 2.57%
21,078 Common Stock
Oct 27 2022
BUY
Grant, award, or other acquisition
-
4,149 Added 16.82%
20,523 Common Stock
Nov 29 2021
SELL
Bona fide gift
-
3,136 Reduced 16.07%
16,374 Common Stock
Oct 28 2021
BUY
Grant, award, or other acquisition
-
1,402 Added 6.7%
19,510 Common Stock
Oct 29 2020
BUY
Grant, award, or other acquisition
-
2,125 Added 10.5%
18,108 Common Stock

Also insider at

MNKPF
Mallinckrodt plc Healthcare
TXMD
TherapeuticsMD, Inc. Healthcare
ESPR
Esperion Therapeutics, Inc. Healthcare
JMC

J Martin Carroll

Director
Somerset, NJ

Track Institutional and Insider Activities on CTLT

Follow Catalent, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTLT shares.

Notify only if

Insider Trading

Get notified when an Catalent, Inc. insider buys or sells CTLT shares.

Notify only if

News

Receive news related to Catalent, Inc.

Track Activities on CTLT